Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
51
Views
18
CrossRef citations to date
0
Altmetric
Original Research

nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial

Josep Tabernero1 Medical Oncology Department, Vall d’Hebron University Hospital, Barcelona, SpainCorrespondence[email protected]
,
Volker Kunzmann2 Medizinische Klinik und Poliklinik II, University of Würzburg, Würzburg, Germany
,
Werner Scheithauer3 Medizinische Universität Wien, Wien, Austria
,
Michele Reni4 San Raffaele Scientific Institute, Milan, Italy
,
Jack Shiansong Li5 Celgene Corporation, Summit, NJ, USA
,
Stefano Ferrara6 Celgene Corporation, Boudry, Switzerland
&
Kamel Djazouli7 Celgene Corporation, Paris, France
 show all
Pages 591-596 | Published online: 02 Feb 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.